Biotech Startup ai3Bio Emerged With $48 Million
The Massachusetts-based firm aims to treat autoimmune diseases by clearing dysregulated T cells starting in 2027.
Live Poll
Do you trust that new medical technologies will effectively manage autoimmune conditions for patients?